Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ThreeLac
- Development stage
- Unknown
- Lead developer
- Global Health Trax
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
ThreeLac is an oral **probiotic dietary supplement** marketed by Global Health Trax for digestive support and maintenance of healthy intestinal flora. It is a **combination microbial product** containing *Bacillus coagulans*, *Bacillus subtilis*, and *Enterococcus faecalis*, and is sold in powder packet and capsule formulations. Rather than acting through a single defined pharmaceutical target, it is intended to modulate the gastrointestinal microbiome by introducing live beneficial bacteria, with marketing focused on digestive symptoms such as occasional diarrhea, constipation, gas, bloating, and on support in the setting of Candida yeast overgrowth. It is not a conventional pharmaceutical drug in clinical development.
- Brand names
- ThreeLac
- Other names
- ThreeLac probiotic dietary supplement
Beyond the preview
Go deeper on ThreeLac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ThreeLac.